133 Review of Advanced Lung cancer treatment in relation to the NLCA report

Lung cancer has the lowest fiver year survival. Prognosis is far worse in people with advanced stage. National Lung cancer Audit 2023 (data period 2021) results showed that only 61% patients with non-small cell lung cancer (stage IIIB - IV, PS 0-1) had systemic cancer treatment. We aim to see if it was a similar trend for the year 2022 and to explore the reasons for any low treatment rate.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Other Source Type: research